Page last updated: 2024-11-07

(2-(trimethylammonium)ethyl)methanethiosulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(2-(trimethylammonium)ethyl)methanethiosulfonate: RN given for bromide; used in dopamine analysis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107933
CHEMBL ID1253297
MeSH IDM0283359

Synonyms (20)

Synonym
mtset cpd
155450-08-1
(2-(trimethylammonium)ethyl)methanethiosulfonate
CHEMBL1253297
2-(trimethylammonium)ethyl-methanethiosulfonate bromide
FT-0675608
n,n,n-trimethyl-2-((methylthio)sulfonyl)ethanaminium bromide
ethanaminium, n,n,n-trimethyl-2-((methylthio)sulfonyl)-, bromide
[2-(trimethylammonium)ethyl]methanethiosulfonate bromide
91774-25-3
mtset
AKOS030239832
DZWJBKUVHJSHAR-UHFFFAOYSA-M
2-[(methanesulfonyl)sulfanyl]-n,n,n-trimethylethan-1-aminium bromide
DTXSID50935217
n,n,n-trimethyl-2-((methylsulfonyl)thio)ethanaminium bromide
trimethyl(2-methylsulfonylsulfanylethyl)azanium;bromide
n,n,n-trimethyl-2-((methylsulfonyl)thio)ethanaminiumbromide
n,n,n-trimethyl-2-[(methylsulfonyl)thio]-ethanaminium bromide
[2-(methanesulfonylsulfanyl)ethyl]trimethylazanium bromide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response analysis showed that treatment with MTSET increased the potency of the FMRFamide in the FaNaC whereas treatment with MTSES reduced the maximum response."( Electrostatic charge at position 552 affects the activation and permeation of FMRFamide-gated Na+ channels.
Furukawa, Y; Kodani, Y, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1660966Inhibition of SrtA delta N24 mutant in Staphylococcus aureus subsp. aureus str. Newman reduction in abundance of anchored SpA by FITC-labeled human IgG fluorescence based assay2020Journal of medicinal chemistry, 08-13, Volume: 63, Issue:15
Tideglusib and Its Analogues As Inhibitors of
AID1660959Covalent inhibition of Staphylococcus aureus SrtA delta N24 mutant expressed in Escherichia coli BL21 (DE3) assessed as reduction in IsdA (64 to 323 residues) transpeptidation incubated for 20 mins followed by 10 fold compound dilution by SDS-PAGE analysi2020Journal of medicinal chemistry, 08-13, Volume: 63, Issue:15
Tideglusib and Its Analogues As Inhibitors of
AID513582Induction of S-nitrosylation of TRPC5 in HEK cells assessed as increase in Ca2+ level from extracellular space at 5 mM extracellular administration2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID1660958Covalent binding affinity to Staphylococcus aureus SrtA delta N24 mutant assessed as induction of m/z shift incubated for 12 hrs by by ESI-LC/MS analysis2020Journal of medicinal chemistry, 08-13, Volume: 63, Issue:15
Tideglusib and Its Analogues As Inhibitors of
AID1660968Inhibition of SrtA delta N24 mutant in Staphylococcus aureus subsp. aureus str. Newman reduction in abundance of anchored SpA by Western blot analysis2020Journal of medicinal chemistry, 08-13, Volume: 63, Issue:15
Tideglusib and Its Analogues As Inhibitors of
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (142)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (8.45)18.2507
2000's106 (74.65)29.6817
2010's23 (16.20)24.3611
2020's1 (0.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.73 (24.57)
Research Supply Index4.97 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other143 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]